Biogen Inc.
- SEC CIK
- 0000875045
No open-market purchases or sales filed in the past year.
Current role at each company
- SGMOQ Sangamo Therapeutics, Inc10% Owneras of Sep 28, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Biogen Inc. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 28, 2023 (view filing)5:30 PM ET | Sep 26 | 2 days | Biogen Inc. and 1 other10% Owner | SSale | −6.00M | $0.50 | −$3.00M | −25.4%17.7M after | |
| Aug 31, 2022 (view filing)7:03 PM ET | Aug 29-30 | 2 days | Biogen Inc. and 1 other10% Owner | SSale | −500.0K | $5.31 | −$2.66M | −2.1%23.7M after | 2 lots |
| Dec 30, 2021 (view filing)5:12 PM ET | Dec 28 | 2 days | Biogen Inc. and 1 other10% Owner | SSale | −2.76K | $8.51 | −$23.5K | 0.0%24.2M after | |
| Dec 28, 2021 (view filing)8:11 AM ET | Dec 23-27 | 5 days | Biogen Inc. and 1 other10% Owner | SSale | −81.8K | $8.55 | −$699.7K | −0.3%24.2M after | 2 lots |
| Dec 10, 2021 (view filing)4:08 PM ET | Dec 9 | 1 day | Biogen Inc. and 1 other10% Owner | SSale | −23.7K | $8.56 | −$202.5K | −0.1%24.2M after | |
| Dec 9, 2021 (view filing)4:08 PM ET | Dec 7-8 | 2 days | Biogen Inc. and 1 other10% Owner | SSale | −128.0K | $8.59 | −$1.10M | −0.5%24.3M after | 2 lots |
| Dec 3, 2021 (view filing)4:09 PM ET | Dec 1-2 | 2 days | Biogen Inc. and 1 other10% Owner | SSale | −2.60K | $8.51 | −$22.2K | 0.0%24.4M after | 2 lots |
| Nov 30, 2021 (view filing)4:20 PM ET | Nov 26 | 4 days | Biogen Inc. and 1 other10% Owner | SSale | −28.9K | $8.60 | −$248.4K | −0.1%24.4M after |